Treatment beyond lifestyle changes generally begins with oral antidiabetic agents, but these medicines only have transitory benefit, and the progressive nature of T2D requires therapeutic intensification to include insulin within 5 to 10 years for many patients (2–4). The gene discussed is INS; the disease is type 2 diabetes mellitus.